119 related articles for article (PubMed ID: 8819075)
21. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
[TBL] [Abstract][Full Text] [Related]
22. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
Faber J; Kantarjian H; Roberts MW; Keating M; Freireich E; Albitar M
Arch Pathol Lab Med; 2000 Jan; 124(1):92-7. PubMed ID: 10629138
[TBL] [Abstract][Full Text] [Related]
23. Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance.
Yasmeen S; Rajkumar A; Grossman H; Szallasi A
Pediatr Dev Pathol; 2017; 20(6):463-468. PubMed ID: 29187045
[TBL] [Abstract][Full Text] [Related]
24. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.
Buresh CJ; Oliai BR; Miller RT
Am J Clin Pathol; 2008 Jun; 129(6):894-8. PubMed ID: 18480005
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity and applicability of different methods for detection of terminal transferase in leukemia.
Sasaki R; Fukushima M; Miura Y; Chang LM; Bollum FJ
Leukemia; 1996 Aug; 10(8):1377-82. PubMed ID: 8709648
[TBL] [Abstract][Full Text] [Related]
26. Biphenotypic M0 acute myeloid leukemia with trisomy-4.
Keung YK; Kaplan B; Douer D
Leuk Lymphoma; 1994 Jun; 14(1-2):181-4. PubMed ID: 7522717
[TBL] [Abstract][Full Text] [Related]
27. Detection of minimal residual disease in acute lymphoblastic leukemia by flow cytometry with monoclonal antibodies.
Imamura N; Kuramoto A
Am J Hematol; 1991 Dec; 38(4):332-4. PubMed ID: 1836104
[TBL] [Abstract][Full Text] [Related]
28. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of the enzyme terminal deoxyribonucleotidyl transferase in lymphoma and leukemia cells].
Bombardieri E; Campagnari F; De Braud F; Clerici L; Maiolo AT; Villa ML; Cappelletti V; Saccani Jotti G; Vezzoni P; Neri A
Acta Biomed Ateneo Parmense; 1984; 55(1):15-23. PubMed ID: 6232800
[TBL] [Abstract][Full Text] [Related]
30. Method for the simultaneous labelling of terminal deoxynucleotidyl transferase (TdT) and membrane antigens.
Tavares de Castro J; San Miguel JF; Soler J; Catovsky D
J Clin Pathol; 1984 Jun; 37(6):628-32. PubMed ID: 6202720
[TBL] [Abstract][Full Text] [Related]
31. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
[TBL] [Abstract][Full Text] [Related]
33. Pathologic diagnosis of acute lymphocytic leukemia.
Lai R; Hirsch-Ginsberg CF; Bueso-Ramos C
Hematol Oncol Clin North Am; 2000 Dec; 14(6):1209-35. PubMed ID: 11147220
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of terminal deoxynucleotidyl transferase as prognosticator in leukemia patients.
Bhatavdekar JM; Trivedi SN; Vora HH; Shukla SN
Int J Biol Markers; 1993; 8(2):77-80. PubMed ID: 8366299
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assay of terminal deoxynucleotidyl transferase (TdT) activity using monoclonal antibodies.
Sasaki R; Yuasa Y; Bollum FJ; Minowada J; Miura Y; Takaku F
Haematologia (Budap); 1991; 24(3):145-52. PubMed ID: 1841845
[TBL] [Abstract][Full Text] [Related]
36. Tdt-positive ALL-L3.
Lenhardt TM; Ganey JT; Hodges GF; Frame JN; Cotelingam JD
Am J Clin Pathol; 1992 May; 97(5):741-2. PubMed ID: 1374216
[No Abstract] [Full Text] [Related]
37. T-cell growth factor (interleukin 2) and terminal transferase activity in human leukemias and lymphoblastic cell lines.
Mertelsmann R; Gillis S; Steinmann G; Ralph P; Stiehm M; Koziner B; Moore MA
Blut; 1981 Aug; 43(2):99-103. PubMed ID: 6942897
[TBL] [Abstract][Full Text] [Related]
38. Clinical utility of leukemia cell terminal transferase measurements.
McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
[TBL] [Abstract][Full Text] [Related]
39. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
40. Characterization of myeloid or lymphoid acute leukemia by a chemiluminescence assay. Comparison with immunocytochemistry using an antimyeloperoxidase antibody.
da Fonseca LM; Brunetti IL; Rego EM; Garcia AB; Cilento G; Falcão RP
Acta Haematol; 1993; 90(1):19-24. PubMed ID: 8237269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
